Effect of second-stage 0.25% epidural bupivacaine on the outcome of labor.
OBJECTIVE
To evaluate the effect of second-stage epidural bupivacaine on the outcome of labor.


METHODS
Two groups of 35 patients each were randomly allocated to receive continuous epidural bupivacaine throughout labor (group 1) or until an 8-cm dilatation of the cervix (group 2).


RESULTS
There was no significant difference between the 2 groups in the rates of instrument deliveries and in their Apgar scores.


CONCLUSIONS
The administration of continuous epidural bupivacaine (0.25%) throughout labor and delivery does not seem to affect the outcome of labor.
Luxman
D
D
Department of Obstetrics and Gynecology, B, Serlin Maternity Hospital, Tel Aviv, Israel.
Wolman
I
I
Niv
D
D
Cohen
J R
JR
Lottan
M
M
Pauzner
D
D
Groutz
A
A
David
M P
MP
D000328:Adult; D015360:Analgesia, Epidural; D016362:Analgesia, Obstetrical; D000704:Analysis of Variance; D001034:Apgar Score; D002045:Bupivacaine / Q000008:administration & dosage*; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007748:Labor Stage, Second; D011247:Pregnancy; D011446:Prospective Studies
D002045:Bupivacaine